FaceHeart Received CES 2024 Innovation Award for FaceHeart Vitals™ in Digital Health

December 25, 2023

FaceHeart, a leading innovator in contactless health measurement software, today announced that it has been named a CESⓇ 2024 Innovation Awards Honoree in the digital health category for FaceHeart Vitals™.

“We are proud to be honored as a CES 2024 Innovation Awards Honoree for our dedicated research and development in image processing and artificial intelligence,” said Dr. Bing-Fei Wu, CEO and founder of FaceHeart, “The acknowledgment highlights the application potential of FaceHeart Vitals™. Moving forward, we aim to integrate with digital health providers to reduce healthcare barriers and improve the accessibility of health measurements.”

The CES Innovation Awards program is an annual competition honoring outstanding design and engineering owned by the Consumer Technology Association (CTA). At CES 2024, FaceHeart will exhibit its award-winning product, FaceHeart Vitals™, from January 9th to 12th in Eureka Park, Booth 62700 at Venetian Expo.

Advancing Health Accessibility Through Contactless Health Measurement

FaceHeart Vitals™, powered by Remote Photoplethysmography (rPPG) technology, contactlessly measures vital signs—including heart rate (HR), blood pressure (BP), oxygen saturation (SpO2), respiration rate (RR), and heart rate variability (HRV)—with medical-grade accuracy. In September, it obtained FDA 510(k) clearance as a class II Software as Medical Device (SaMD) for heart rate measurement, marking a significant milestone as the first FDA-cleared rPPG solution on the market.

Facilitating seamless integration, FaceHeart offers software development kits (SDK) compatible with various devices and online services. In addition to transferable data formats, FaceHeart Vitals™ SDK supports multiple operating systems including iOS, Android, Windows, and Linux, enabling adaptable measurements across smartphones, tablets, computers, smart home devices, and embedded boards.

Driving Progress in Health Technology

With the FDA clearance and the esteemed CES 2024 Innovation Award, FaceHeart is committed to expanding its commercial and development ventures. To verify the accuracy and optimize the algorithm, FaceHeart has collected over 150 million datasets from over 5000 testers in clinical trials. Future endeavors include actively seeking additional medical certifications across various regions and vital signs. Using a simple camera, FaceHeart Vitals™ brings high-quality healthcare into the hands of individuals, empowering telemedicine, remote patient monitoring, digital therapy, and decentralized clinical trials to monitor end-users' health status. Additionally, FaceHeart expects to expand collaboration with corporate wellness programs and smart home appliances, transforming how we approach personal health in everyday life.

About FaceHeart

FaceHeart Corporation improves human health through its expertise in artificial intelligence, computer vision, and deep learning. Through FaceHeart's technology, individuals can access high-quality health services with minimal accommodations. For more information on FaceHeart, please visit faceheart.com or contact us via marketing@faceheart.com.